VS
stockvs
Go to ScreenerHub
LLY

LLY vs NVO

NVO

In the past 12 months, LLY returned +57% while NVO lost 16%.

LLY
LLY

Eli Lilly and Company

$1,159.50
3.4%(1M)
Market Cap1.1T
Healthcare
Drug Manufacturers - General
USA
P/E Ratio38.97
ROE92.6%
P/B Ratio30.64
Dividend Yield0.6%
NVO
NVO

Novo Nordisk A/S

$47.51
0.9%(1M)
Market Cap211B
Healthcare
Drug Manufacturers - General
DK
P/E Ratio11.50
ROE59.1%
P/B Ratio6.04
Dividend Yield2.5%
Performance Comparison

Historical returns across multiple timeframes

LLY leads 6/8
LLY

LLY

Eli Lilly and Company

+57.1%

1Y Return

NVO

NVO

Novo Nordisk A/S

-16.3%

1Y Return

LLY
LLY
NVO
NVO

Short Term

1M-6M

NVO
+14.5%

Medium Term

YTD-1Y

LLY
+32.5%

Long Term

3Y-10Y

LLY
+610.5%

Valuation

Compare price multiples and valuation ratios

LLY: 0NVO: 5
MetricLLYNVOWinner
P/E Ratio

Price to earnings ratio

38.9711.50NVO
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

13.754.07NVO
P/B Ratio

Price to book ratio

30.646.04NVO
P/FCF Ratio

Price to free cash flow ratio

54.6327.39NVO
EV/EBITDA

Enterprise value to EBITDA

32.348.30NVO
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

LLY: 3NVO: 3
MetricLLYNVOWinner
Gross Margin

Gross profit margin

84.0%80.6%LLY
Operating Margin

Operating profit margin

43.9%43.1%LLY
Net Margin

Net profit margin

33.5%35.3%NVO
ROE

Return on equity

92.6%59.1%LLY
ROA

Return on assets

18.8%19.6%NVO
ROIC

Return on invested capital

27.4%29.7%NVO

Growth

Compare revenue and earnings growth rates

LLY: 6NVO: 0
MetricLLYNVOWinner
Revenue Growth (YoY)

Year-over-year revenue growth

44.7%6.4%LLY
Revenue Growth (3Y)

3-year revenue CAGR

31.7%20.4%LLY
Revenue Growth (5Y)

5-year revenue CAGR

21.6%19.5%LLY
EPS Growth (YoY)

Year-over-year EPS growth

96.0%1.8%LLY
EPS Growth (3Y)

3-year EPS CAGR

51.7%23.5%LLY
EPS Growth (5Y)

5-year EPS CAGR

28.8%20.7%LLY

Balance Sheet & Risk

Compare financial stability and debt levels

LLY: 2NVO: 3
MetricLLYNVOWinner
Debt/Equity

Debt to equity ratio

1.620.63NVO
Current Ratio

Current assets to current liabilities

1.350.87LLY
Quick Ratio

Quick assets to current liabilities

1.000.66LLY
Interest Coverage

EBIT to interest expense

35.7286.86NVO
Beta

Stock volatility vs market

0.510.35NVO
Summary
NVO wins 2-1

Valuation

NVO

Profitability

Tie

Growth

LLY

Balance Sheet

NVO

NVO is more attractively valued. LLY demonstrates better growth. NVO has a stronger balance sheet.

Related Comparisons
Take Your Analysis Further

Dive deeper into LLY and NVO with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/LLY/vs/NVO" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare LLY vs NVO on stockvs.app
</a>